Aaron Pilling, Ph.D.

Dr. Aaron Pilling is an experienced professional with nearly 20 years of expertise in biologics process design. He has provided technical leadership over a wide range of molecule types and has been involved in multiple stages of development and commercialization. Aaron started his career at Cook Pharmica, where he helped to establish and build the mammalian cell culture process development team. Later, he transitioned to Amgen and supported multiple end-to-end late-stage antibody and biosimilar programs through process characterization, technology transfer, control strategy development, manufacturing, and commercialization. At KBI Biopharma, Aaron was Senior Director, head of the process development, responsible for cell line development, upstream, solubilization/refold, and downstream process design for integrated client programs. In this role, he was responsible for new client engagement, business development/sales, proposal development, technology and innovation efforts, and launching new CDMO service offerings. Aaron is an expert on CDMO organizations, their strengths, weaknesses, and areas of specialization. He can lead large cross-functional technical teams towards coordinated common goals and intentions. Technically, he is a subject matter expert in process design - early to late stage, process characterization, mammalian and microbial expression products, risk assessment methodologies, control strategy design, technology transfer, analytical comparability evaluations, and contamination investigations (Viral, Microbial, Bacteriophage). Aaron received a PhD in Molecular, Cell, and Developmental Biology from Indiana University and did Post-Doctoral Research at the University of Pennsylvania.